BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC
BusinessCrown Bioscience Announces Record Breaking Growth With First 2017 Quarter ResultsBy Nasdaq OMXMay 19, 2017, 11:57 AM UTC
BusinessCrown Bioscience Announces Record Breaking Growth With First 2017 Quarter ResultsBy Nasdaq OMXMay 19, 2017, 11:57 AM UTC
BusinessNew Clinical and Biomarker Data Validate Immune Design’s Lead Programs and Discovery PlatformsBy Nasdaq OMXMay 17, 2017, 8:35 PM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory BoardBy Nasdaq OMXMay 17, 2017, 11:01 AM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory BoardBy Nasdaq OMXMay 17, 2017, 11:01 AM UTC
BusinessTESARO Partners With Clinigen to Initiate European Managed Access Program for Niraparib in Patients With Recurrent Ovarian CancerBy Nasdaq OMXMay 11, 2017, 6:01 AM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
